Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Jaguar Health has tendered its last key regulatory application towards US approval of Canalevia for chemotherapy-induced diarrhea (CID) in dogs.
US investment bank William Blair said a healthy rebound is occurring in veterinary practice revenues.
A dog in North Carolina previously suspected of being infected by COVID-19 likely never had the virus, according to the USDA.
Kindred Biosciences expects its next US approval to be for its canine parvovirus monoclonal antibody (mAb) in early 2021.
Carus Animal Health has a mandate to search for innovation that it can take from the human healthcare sector into animal health. Despite the coronavirus pandemic, the company has made headway with some of its key partnerships. Animal Pharm editor Joseph Harvey had a virtual chat with Carus commercial director Jolian Howell to find out the latest progress.
The quest for animal health innovation has accelerated tremendously over recent years, as leading players develop strategies to offset the maturation of product portfolios.
The US FDA has approved Vetoquinol's parasiticide Imoxi Topical Solution for Cats.
Zomedica Pharmaceuticals is seeking around $20 million from a public offering of shares.
A survey has found the most negative impact of the COVID-19 pandemic on veterinary practices has been in clinic visits and over-the-counter (OTC) medications.
There have been two new reports of COVID-19 virus infection in pets in the past few weeks, according to the OIE.
US firm Anivive Lifesciences has submitted an application to the US FDA to repurpose its GC376 feline drug for COVID-19 in humans.
While the trend of digitally focused business in animal health started to grow before COVID-19, the companion animal sector is now witnessing an even greater uptake of technology.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.